IL-6/GP130 SIGNALING AS A NOVEL CHEMOPREVENTION TARGET FOR TRIPLE-NEGATIVE BREAST CANCER

$1,126,850FY2020Defense Health AgencyDOD

Wake Forest University Health Sciences, Winston-Salem NC

Investigators